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Abstract 
Background: The error-related negativity (ERN) is a negative deflection in the event-related 
potential following a mistake that is often increased in patients with obsessive-compulsive 
disorder (OCD). The relationship of the ERN to comorbid major depressive disorder (MDD) 
has not been examined in adolescents with OCD. This study compared ERN amplitudes in 
OCD patients with MDD (OCD+MDD), OCD patients without MDD (OCD-MDD), MDD 
patients, and healthy controls (HC).  
Method: The ERN, correct response negativity, and accuracy were measured during a 
flanker task to assess performance monitoring in 53 adolescents with a lifetime diagnosis of 
OCD, 36 adolescents with a lifetime diagnosis of MDD, and 89 matched HC ages 13 to 18 
years. Fourteen OCD patients had a history of MDD.  
Results: ERN amplitude was significantly increased in OCD patients compared to HC and 
significantly correlated in OCD patients with age at OCD symptom onset, particularly in the 
OCD-MDD patients. The ERN was significantly enlarged in OCD+MDD patients compared 
to HC, but not in MDD patients compared to HC. There was a trend for an increased ERN 
amplitude in OCD-MDD patients compared to HC. OCD patients were significantly less 
accurate than either MDD patients or HC. 
Conclusions: An enlarged ERN is a neural correlate of adolescent OCD that is associated 
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control on a flanker task. Follow-up studies with larger samples may determine whether an 
enlarged ERN in adolescents with OCD is associated with a higher risk for MDD.  
 
 
Increased Error-Related Brain Activity in Adolescents with  
Obsessive-Compulsive Disorder and Major Depressive Disorder 
 
1 | INTRODUCTION 
 Major depressive disorder (MDD) is the mood disorder most frequently associated 
with obsessive-compulsive disorder (OCD) (Ruscio, Stein, Chiu, & Kessler, 2010). In youth 
with OCD, adolescents had a six-fold greater likelihood of a comorbid depressive disorder 
than their younger counterparts (Peris et al., 2017). The findings are consistent with 
longitudinal studies in which depression onset appears to peak between the ages of 15 and 18, 
especially among females (Hankin et al., 1998). Twin and family studies indicate the overlap 
between OCD and MDD in adolescents is primarily due to shared genetic factors (Bolhuis et 
al., 2014; Hanna et al., 2011). However, a putative biomarker for OCD has not been 
examined in youth with OCD and MDD.     
The error-related negativity (ERN or Ne) is a negative deflection in the response-
locked event-related potential that peaks within 80 ms after an erroneous response 
(Falkenstein, Hohnsbein, Hoormann, & Blanke, 1991; Gehring et al., 1993). The ERN 
appears to reflect the activity of a system that detects errors, increases cognitive control, and 
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indicating it may serve as an endophenotype in genetic studies of psychopathology (Anokhin, 
Golosheykin, & Heath, 2008). The ERN is a unit of measurement in the Research Domain 
Criteria (RDoC) matrix in three different domains and constructs: cognitive systems 
(cognitive control), negative valence systems (sustained threat), and positive valence systems 
(reward learning) (Weinberg, Dieterich, & Riesel, 2015).
 
Its placement in those domains 
suggests it can reflect interactions between cognitive and motivational factors. 
Increased ERN amplitudes have been found in most studies of OCD patients using 
tasks eliciting response conflict (Endrass, & Ullsperger, 2014). An enlarged ERN has been 
detected in unaffected first-degree relatives of OCD probands, demonstrating that overactive 
performance monitoring may occur in relatives at risk for developing OCD (Carrasco et al., 
2013; Riesel, Endrass, Kaufmann, & Kathmann, 2011). Most studies reporting an enhanced 
ERN in OCD patients have detected no association between the ERN and OCD symptom 
severity (Riesel, Endrass, Auerbach, & Kathmann, 2015). Those observations suggest the 
ERN is a state-independent measure that may serve as a biomarker or endophenotype for 
OCD (Weinberg, Dieterich, & Riesel, 2015). In a study finding decreased accuracy but an 
enlarged ERN in youth with OCD, the ERN was more strongly associated with Child 
Behavior Checklist/6-18 (CBCL/6-18) Withdrawn/Depressed Scale scores than with a 
lifetime diagnosis of OCD, suggesting that MDD symptoms may account for a significant 
portion of the ERN variance in OCD patients (Achenbach, & Rescorla, 2001; Hanna et al., 
2016). However, in studies of MDD patients, ERN amplitudes have been increased (Aarts et 
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Schrijvers et al., 2007), or similar to those of healthy controls (HC) (Olvet, Klein, & Hajcak, 
2010; Schrijvers et al., 2009). 
Because the relationship of the ERN to comorbid MDD has not been examined in 
youth with OCD, the following study was conducted in 53 adolescents with a lifetime 
diagnosis of OCD, 36 adolescents with a lifetime diagnosis of MDD, and 89 age-matchedHC. 
Fourteen OCD patients had a history of MDD. The first aim was to compare accuracy and 
ERN amplitudes in OCD patients, MDD patients, and HC, followed by similar comparisons 
in OCD patients with MDD (OCD+MDD), OCD patients without MDD (OCD-MDD), MDD 
patients, and HC. The second aim was to examine the relationship of the ERN to the CBCL 
Problem Scales in patients and HC. The CBCL/6-18 DSM-Oriented Scales (DOS) were used 
in this analysis because they may more clearly differentiate affective from anxiety symptoms 
than the CBCL/6-18 Syndrome Scales (Spatola et al., 2007). 
2 | MATERIALS AND METHODS 
2.1 | Participants 
 OCD and MDD patients were recruited from the Department of Psychiatry at the 
University of Michigan and surrounding community. HC were recruited from the surrounding 
community and matched to patients by age and sex. Participants or their parents gave written 
informed consent in accordance with the Declaration of Helsinki. All tasks and procedures 
were approved by the University of Michigan Medical School Institutional Review Board. 
Participants were paid for their interviews and psychophysiological recordings. Some 
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commission of fewer than 10 errors (n = 15), leaving a total of 178 participants. The final 
sample consisted of 41 males and 137 females ages 13 to 18 years, with an ethnic and racial 
breakdown that was 91% Caucasian, 2% Black, 4% Latino, 1% Asian, and 2% Native 
American. 
 The 89 patients had a lifetime diagnosis of OCD without MDD (OCD-MDD) (n = 
39), a lifetime diagnosis of MDD without OCD (MDD) (n = 36), or lifetime diagnoses of 
both disorders (OCD+MDD) (n = 14). Patients were excluded if they had a lifetime diagnosis 
of schizophrenia, bipolar disorder, substance-related disorder, or anorexia nervosa. All 89 HC 
had no history of a specific axis I disorder. Lifetime and current axis I diagnoses were made 
independently by two clinicians using all sources of information according to DSM-5 criteria 
(American Psychiatric Association, 2013). Participants were excluded if they had a history of 
intellectual disability, head injury with loss of consciousness, chronic neurological disorder, 
or scores higher than 14 on the Social Communication Questionnaire (SCQ; Berument et al., 
1999). Tables 1 and 2 summarize the demographic, clinical, behavioral, and event-related 
brain potential data for the participants. Because studies have found that treatment with a 
selective serotonin reuptake inhibitor (SSRI) has no effect on the ERN, 36 patients were 
enrolled taking a stable dose of an SSRI but no other psychotropic medications (Stern et al., 
2010). 
2.2 | Measures 
All 178 participants were interviewed with the Schedule for Schizophrenia and 
Affective Disorders for School-Aged Children-Present and Lifetime Version (Kaufman et al., 
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2013). The maximum and current severity of OCD symptoms was assessed with the 
Children’s Yale-Brown Obsessive Compulsive Disorder Scale (CY-BOCS; Scahill et al., 
1997). Parents completed the CBCL/6-18 (Achenbach, & Rescorla, 2001) and SCQ 
(Berument et al., 1999) about their children. 
2.3 | Stimulus material and task procedures 
 Participants performed an arrow version of the flanker task in which arrows appeared 
on a computer display with congruent (e.g., →→→→→) and incongruent (e.g., →→←→→) 
conditions (Eriksen, & Eriksen, 1974). They were instructed to respond by pressing one of 
two buttons indicating the direction of the central arrow (i.e., right versus left), while ignoring 
the adjacent arrows, and to respond as quickly and accurately as possible, placing equal 
emphasis on speed and accuracy. The stimuli remained on the screen for 250 ms, with an 
interval of 1,500 ms between consecutive stimuli. Each participant was seated 0.65 meters 
directly in front of the computer monitor. Following 32 practice trials, each subject 
completed 8 blocks of 64 trials with the number of completed trials ranging from 256 to 512. 
Performance feedback was provided after every block to yield an error rate of approximately 
10%, with encouragement to focus on speed if there were fewer than four errors or to focus 
on accuracy if there were more than ten errors (Hanna et al., 2016). 
2.4 | Electrophysiological recording and data reduction 
 The EEG was recorded from DC-104 Hz with 64 Ag/AgCl scalp electrodes, two 
mastoid electrodes, and two vertical and two horizontal electro-oculogram electrodes, using 




This article is protected by copyright. All rights reserved. 
8 
 
formed from a common mode sense active electrode and driven right leg passive electrode 
(see http://www.biosemi.com/faq/cms&drl.htm), and re-referenced offline to the average of 
the two mastoid electrodes. Data were band-pass filtered 0.1-30Hz using zero-phase shift 
filters. EEG data were screened using automated algorithms that rejected epochs in which 
absolute voltage exceeded 500 µV and epochs containing peak to peak activity greater than 
500 µV within 200 ms, with a 100msec moving window, for midline channels (Fz, FCz, Cz, 
CPz, Pz). Ocular movement artifacts were then corrected using a regression-based algorithm 
(Gratton, Coles, & Donchin, 1983). After ocular correction, individual trials were rejected if 
they contained absolute amplitudes greater than 100 µV, a change greater than 50 µV 
measured from one data point to the next point, or a maximum voltage difference less than 
0.5 µV within a trial in any of the midline electrodes.  
Behavioral measures included the number of erroneous and correct trials for each 
subject, as well as accuracy expressed as a percentage of valid trials. Mean reaction times on 
error and correct trials were calculated separately, and trials were excluded if their reaction 
times were more than 3 standard deviations from the mean. Reaction time and accuracy after 
errors were evaluated to determine if there were group differences in post-error behavioral 
adjustments (Gehring, Liu, Orr, & Carp, 2012). Reaction times were analyzed with group as a 
between-subject factor and response type as a within-subject factor. The mean number of 
errors per subject contributing to the analysis was 41.9 (SD = 22.6; range = 10 to 133). 
 The ERN was quantified using mean amplitude measures relative to a pre-response 
baseline -200 to -50 msec. The mean amplitude of the ERN was computed on incorrect 
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response negativity (CRN) consisted of the same measure computed on correct response 
trials. The ∆ERN was calculated by subtracting the CRN from the ERN because it may 
isolate activity unique to error processing from activity more broadly related to response 
monitoring (Gehring, Liu, Orr, & Carp, 2012). Amplitudes were calculated for electrodes 
FCz, Cz, and CPz; however, the focus of the data presented herein is the ERN at Cz because 
prior studies have found larger group differences at that electrode (Hanna et al., 2016).   
2.5 | Statistical analyses 
Student t-tests or χ
2 
tests were used to evaluate group differences in demographic data. 
Pearson correlation coefficients were used to examine associations of response-related 
amplitudes with age, behavioral measures, and clinical measures. Clinical and behavioral data 
were analyzed using an analysis of covariance (ANCOVA) with group (OCD patients, MDD 
patients, HC) as a between-subject factor and age as a covariate. Electrocortical indicators 
(ERN, CRN) of performance monitoring were analyzed separately using a repeated-measure 
ANCOVA with group (OCD patients, MDD patients, HC) as a between-subject factor and 
response type (correct, error) as a within-subject factor and with age and accuracy as 
covariates (Gehring, Liu, Orr, & Carp, 2012). These analyses were repeated to examine 
performance monitoring in OCD patients with and without MDD.
 
Analyses were performed 
with JMP Version 12 software. All tests were two-tailed with α = 0.05.  
3 | RESULTS 
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 Participants were significantly more accurate on congruent than incongruent trials 
(paired t (117) = 26.64, P < .0001). HC and MDD patients were significantly more accurate 
than OCD patients on all trials (Table 1). There were no significant group differences in 
reaction time during correct or incorrect trials or in post-error slowing. Correct responses 
were significantly slower than incorrect responses, paired t (117) = 9.72, P < .0001. No main 
effect of group and no interaction between group and response type for reaction time reached 
significance (P = .20 and P = .24, respectively). Age in all subjects had significant negative 
correlations with reaction time on correct (r = -.22, P = .003) and incorrect trials (r = -.15, P 
= .04), but had no significant correlation with post-error slowing (P = .76). Age in all subjects 
had no significant correlations with accuracy, post-correct accuracy, post-error accuracy, or 
post-error slowing (all P values > .2). There were no significant sex differences in accuracy, 
post-correct accuracy, post-error accuracy, or post-error slowing (all P values > .2). 
Medication status was not significantly associated with accuracy in patients (all P values > 
.4). 
3.2 | Event-related potential data in OCD patients, MDD patients, and healthy controls 
Age in all participants had a significant correlation with CRN amplitudes (r = .21, P = 
.005), but not with ERN amplitudes (P = .43), indicating that smaller (less negative) CRN 
amplitudes were associated with increasing age. Accuracy in all participants had a significant 
correlation with the ERN (r = -.24, P = .002), but not with the CRN (P = .15). ERN 
amplitudes in all participants had no significant correlations with reaction times on either 
correct or incorrect trials or with post-error slowing (all P values > .4). CRN amplitudes had 
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incorrect trials (r = -.38, P < .0001), but not with post-error slowing (P = .11). There were no 
significant sex differences in any brain potentials (all P values > .19). 
In a comparison of ERN amplitudes in the three groups, there was a significant group 
effect, F (2, 173) = 3.69, P = .027, with a significant effect for accuracy, F (1, 173) = 14.54, 
P = .0002, but not for age, P = .46 (Table 1; Figure 1). The ERN was significantly enlarged 
in OCD patients compared to HC, F (1, 138) = 7.82, P = .006, Cohen’s d = 0.27. ERN 
amplitudes were not significantly different either between OCD patients and MDD patients 
(P = .17) or MDD patients and HC (P = .49). In a comparison of CRN amplitudes in the three 
groups, there was no significant group effect (P = .73). 
3.3 | Even-related potential data in OCD+MDD patients, OCD-MDD patients, MDD 
patients, and healthy controls  
 In a comparison of ERN amplitudes in the four groups, there was a significant group 
effect, F (3, 172) = 2.98, P = .033, with a significant effect for accuracy, F (1, 172) = 13.51, 
P = .0003, but not for age, P = .61 (Table 2; Figure 2). The ERN was significantly enlarged 
in OCD+MDD patients compared to HC, F (1, 99) = 6.71, P = .011, Cohen’s d = 0.60. There 
were trends for an enhanced ERN in both OCD+MDD patients compared to MDD patients, F 
(1, 46) = 3.70, P = .06, and OCD-MDD patients compared to HC, F (1, 124) = 3.40, P = .07, 
Cohen’s d = 0.14. The ERN was not significantly enlarged in either OCD+MDD patients 
compared to OCD-MDD patients (P = .18) or OCD-MDD patients compared to MDD 
patients (P = .84). In a comparison of CRN amplitudes in the four groups, there was no 
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3.4 | Clinical and event-related potential data in OCD patients, MDD patients, and 
healthy controls 
 There were no significant differences in any brain potentials between patients with a 
current diagnosis of OCD and those with a past diagnosis of OCD (all P values > .2). There 
were no significant correlations in OCD patients between any brain potentials and either 
current or maximum CY-BOCS scores (all P values > .3). The ERN had a significant 
correlation with age at onset of OCD symptoms in OCD patients (r = .29, P = .04), indicating 
that larger (more negative) ERN amplitudes were associated with an earlier onset. The age at 
onset correlation was significant in OCD-MDD patients (r = .43, P = .007), but not in 
OCD+MDD patients (r = -.22, P = .46). The ERN had a significant correlation with CBCL/6-
18 Anxiety Problems scores in the total sample (r = -.27, P = .0003) (Table 3). The 
correlation was significant in OCD patients (r = -.46, P = .006), but not in MDD patients (P = 
.12) or HC (P = .98), indicating that larger (more negative) ERN amplitudes were associated 
with more severe anxiety symptoms in OCD patients but not in MDD patients or HC. The 
ERN had a significant correlation with CBCL/6-18 Affective Problems scores in the total 
sample (r = -.15, P = .04), but not in the three groups considered separately (all P values > 
.1). Accuracy had a significant correlation with CBCL/6-18 Anxiety Problems scores in OCD 
patients (r = .35, P = .013), but not in MDD patients (P = .29) or HC (P = .19). 
4 | DISCUSSION 
 Consistent with previous studies of performance monitoring, we found an enlarged 
ERN in adolescents with OCD compared to HC during a task eliciting response conflict 
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CPz but not at FCz, suggesting that error-related brain activity is localized more posteriorly 
in adolescents with OCD than in HC. Consistent with a previous study of youth ages 10 to 19 
(Hanna et al., 2012), a larger (more negative) ERN in adolescents with OCD was associated 
with an earlier age at OCD symptom onset; however, that correlation remained significant in 
OCD-MDD patients but not in OCD+MDD patients. As in most studies of the ERN in OCD, 
there was no association between the ERN and OCD symptom severity as measured by either 
the CY-BOCS or current diagnostic status (Weinberg, Dieterich, & Riesel, 2015). However, 
the ERN had a significant correlation with CBCL/6-18 Anxious Problems scores in OCD 
patients but not in MDD patients or HC, indicating that non-OCD anxiety symptoms may 
account for a significant portion of the ERN variance in OCD patients and perhaps parallel 
the anxious arousal noted in the RDoC sustained threat construct (Weinberg, Dieterich, & 
Riesel, 2015). 
 The ERN was significantly enlarged in OCD+MDD patients compared to HC, 
whereas there was a trend for a larger ERN in OCD-MDD patients compared to HC. The 
ERN increase in OCD+MDD patients is consistent with the hypothesis that the ERN is 
associated with the anhedonic and avoidant behaviors described in the RDoC sustained threat 
construct (Hanna et al., 2016). It is possible that the enlarged ERN in OCD+MDD patients is 
at least partially due to genetic factors shared by both disorders (Bolhuis et al., 2014). 
Follow-up studies with larger samples may determine whether an enlarged ERN in 
adolescents with OCD is associated with a higher risk for MDD (Peris et al., 2017). 
ERN amplitudes were not significantly different either between MDD patients and 
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MDD patients and HC is consistent with some studies of the ERN in adults with MDD 
(Olvet, Klein, & Hajcak, 2010; Schrijvers et al., 2009). However, a previous study requiring 
at least 20 error trials for each participant found significantly decreased ERN amplitudes in 
youth with MDD compared to HC (Ladouceur et al., 2012). We repeated our analyses using 
32 MDD patients and 75 HC each with at least 20 errors trials, but found no significant group 
difference in the ERN (data not shown).      
 In contrast to studies observing fewer errors in adults with OCD (Riesel, Endrass, 
Auerbach, & Kathmann, 2015; Riesel, Endrass, Kaufmann, & Kathmann, 2011), we found 
that adolescents with OCD were less accurate than either HC or MDD patients. Our previous 
study also found that OCD patients ages 8 to 18 were less accurate than HC (Hanna et al., 
2016), indicating that youth with OCD have impaired cognitive control on a flanker task. 
However, accuracy in OCD patients still had a significant negative correlation with the ERN 
in the present study, becoming larger (more negative) as accuracy improved. Accuracy had a 
significant positive correlation with CBCL/6-18 Anxiety Problems scores in OCD patients, 
but not in MDD patients or HC, indicating that more severe anxiety symptoms did not 
interfere necessarily with task performance in OCD patients. A meta-analysis found no 
noteworthy neuropsychological deficits in youth with OCD, although a flanker task was not 
included in those tests (Abramovitch et al., 2015). Given our findings in OCD+MDD 
patients, it is possible that cognitive control deficits coupled with increased sensitivity to 
sustained endogenous threat may be associated with more severe depressive symptoms in 
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Our study has limitations requiring further consideration. The MDD group was 
significantly older than the OCD-MDD group. Moreover, the number of OCD and MDD 
patients was low, so the findings regarding accuracy and the ERN require replication in 
studies with larger samples and broader age ranges. Treatment was not controlled; 
nonetheless, there is no evidence that either cognitive-behavior therapy or SSRI treatment 
alter ERN amplitudes (Kujawa et al., 2016). The MDD group was necessary to assess the 
specificity of an enlarged ERN in the OCD+MDD group and is a notable strength of the 
study.     
5 | CONCLUSION 
Our study provides evidence that an enlarged ERN is a neural correlate of adolescent 
OCD that is related to age at OCD symptom onset. Despite having an enlarged ERN, OCD 
patients were less accurate than either MDD patients or HC indicating that adolescents with 
OCD may have impaired cognitive control on a flanker task (Hanna et al., 2016). The 
relationship between the ERN and risk for MDD warrants further research in youth with 
OCD, as it may provide a better understanding of the pathogenesis of both disorders and lead 
to new prevention and treatment strategies (Peris et al., 2017). 
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TABLE 1. Demographic, clinical, behavioral, and brain potential data in OCD patients, 
MDD patients, and healthy controls 
__________________________________________________________________________________
___________________________________ 
               OCD group            MDD group            HC 
group                    Comparisons of OCD,  
                  n = 53                n = 36                    n 
=89                    MDD, and HC groups 
                    ____________           ___________           
___________                ________________________ 
Variable                         Mean (SD)             Mean (SD)       Mean 
(SD)                    Test Statistic             P 
__________________________________________________________________________________
___________________________________ 
Demographic and Clinical Data 
Age (years)                15.9 (1.8)†             16.8 (1.4)       16.2 
(1.8)                     F (2, 175) = 2.92     .056  
Sex (M/F)            14 / 39     7 / 29         20 / 
69                           χ
2 
(2) = 0.62     .73  
SSRI (treatment/no treatment)         25 / 28   11 / 25  
                 χ
2 
(1) = 2.46     .12 
Child Behavior Checklist 
   Obsessive-Compulsive Problems                  5.5 (3.7)***†††       3.0 (2.4)***           0.9 
(1.0)                    F (2, 174) = 60.7   <.0001 
   Total score                   33.3 (23.7)***         41.0 (27.8)***         8.6 








  Internalizing score                  13.3 (9.6)***†         17.1 (10.5)***         3.2 
(3.2)                    F (2, 174) = 57.5   <.0001   
 
   Externalizing score                    6.5 (6.7)***             8.4 (9.4)***           2.1 
(3.4)                   F (2, 174) = 17.2   <.0001   
 
   Affective Problems         4.7 (4.2)***††   7.8 (4.9)***         0.6 
(1.0)       F (2, 174) = 68.2   <.0001 
   Anxiety Problems         3.8 (3.0)***   3.8 (2.9)***         0.6 
(1.0)       F (2, 174) = 48.8   <.0001 
   Somatic Problems         1.9 (2.6)**               3.1 (2.9)***          0.7 
(1.4)       F (2, 174) = 17.3   <.0001    
   Attention Deficit/Hyperactivity Problems      2.8 (3.1)***   2.9 (2.7)***          0.9 
(1.7)       F (2, 174) = 14.9   <.0001    
   Oppositional Defiant Problems       2.3 (2.1)***             2.9 (2.5)***          0.9 
(1.4)       F (2, 174) = 17.9   <.0001    
   Conduct Problems         1.3 (2.4)*               2.4 (4.4)***          0.5 
(1.3)       F (2, 174) =   6.4     .002    
Social Communication Questionnaire                 3.5 (2.9)***    2.9 (2.4)*        1.7 
(2.1)                 F (2, 174) =   9.6    <.0001 Behavioral Data 
Total number of trials                      484.2 (54.2)           501.3 (34.0)     490.6 
(53.1)       F (2, 174) = 1.05      .35 Total number of error trials             50.4 
(27.9)**†        38.4 (16.9)       38.2 (19.7)                 F (2, 174) = 5.28      .006     Accuracy 
on all trials                    0.89 (.05)*** ††      0.92 (.03)       0.92 (.04)                   
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Accuracy on congruent trials                   0.97 (.03)*               0.98 (.02)       0.98 
(.02)                   F (2, 174) = 2.97       .054   Accuracy on incongruent trials                  
0.81 (.09)*** ††       0.86 (.06)       0.86 (.06)       F (2, 174) = 8.11      .0004 
Accuracy after correct trials                   0.89 (.05)***†         0.92 (.04)       0.92 
(.04)                   F (2, 174) = 6.85      .0014 
Accuracy after incorrect trials       0.89 (.09)**†††   0.96 (.04)       0.93 
(.06)              F (2, 174) = 8.66      .0003   Error reaction time (ms)                   
390.0 (102.3)           365.6 (34.6)     409.5 (147.8)         F (2, 174) = 1.50      .23 
Correct reaction time (ms)                     440.1 (79.6)             423.4 (35.1)     447.7 
(90.1)                  F (2, 174) = 0.84      .43 
Reaction time on congruent trials (ms)    411.9 (69.8)             395.8 (32.0)     418.6 
(78.3)                  F (2, 174) = 0.93      .40    
Reaction time on incongruent trials (ms)    474.4 (96.0)             455.2 (41.1)     481.2 
(105.1)     F (2, 174) = 0.68      .51 
Post-error slowing (ms)                              55.1 (33.1)†             67.8 (40.7)*       41.1 
(66.8)                 F (2, 174) = 3.34      .038 
Event-Related Brain Potential Data 
Error-related negativity, FCz (µV)               -4.88 (6.16)             -5.14 (5.24)      -4.18 
(5.46)                   F (2, 173) = 1.27      .28            
Correct response negativity, FCz (µV)              3.16 (4.93)            3.55 (5.08)              3.24 
(4.34)                 F (2, 173) = 0.04       .96  
Error-related negativity, Cz (µV)               -2.76 (5.76)*          -2.11 (5.14)      -1.17 
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Correct response negativity, Cz (µV)                 4.18 (5.32)             4.97 (5.94)              4.60 
(4.86)                 F (2, 173) = 0.32       .72     
Error-related negativity, CPz (µV)                 1.18 (4.73)**         2.07 (4.36)        2.74 
(5.28)      F (2, 173) = 4.60       .01            
Correct response negativity, CPz (µV)               5.53 (5.31)            6.19 (4.86)        5.41 
(4.73)                 F (2, 173) = 0.23       .80 
∆ERN, FCz (µV)       -8.04 (6.90)           -8.69 (6.53)       -7.42 
(6.52)      F (2, 173) = 0.70       .50 
∆ERN, Cz (µV)       -6.94 (6.66)           -7.08 (7.76)       -5.77 
(6.56 )      F (2, 173) = 1.39       .25 
∆ERN, CPz (µV)       -4.35 (6.11)           -4.11 (6.50)       -2.67 
(5.56)      F (2, 173) = 2.40       .09 
__________________________________________________________________________________
___________________________________ 
OCD, obsessive-compulsive disorder;  
MDD, major depressive disorder; 
SSRI, selective serotonin reuptake inhibitor; 
∆ERN, error-related negativity amplitude minus correct response negativity amplitude. 
*P < .05 compared to HC, **
 
P < .01 compared to HC, ***P < .001 compared to HC. 
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TABLE 2. Demographic, clinical, behavioral, and brain potential data in OCD patients 
with MDD, OCD patients without MDD, MDD patients, and healthy controls 
__________________________________________________________________________________
___________________________________ 
           OCD+MDD       OCD-MDD             MDD                   
HC                           Group   
                   n = 14               n = 39                n =36        
n = 89                    comparisons            
           ___________        ___________       ___________       
___________       _______________________ 
Variable                         Mean (SD)         Mean (SD)  Mean (SD)    
Mean (SD)            Test Statistic           P 
__________________________________________________________________________________
___________________________________ 
Demographic and Clinical Data 
Age (years)            16.6 (1.6)           15.6 (1.4)†   16.8 (1.4)          
16.2 (1.7)          F (3, 174) = 3.76       .012  
Sex (M/F)                1 / 13   13 / 26                 7 / 29        
20 / 69                  χ
2 
(3) = 4.61       .20    
SSRI (treatment/no treatment)             7 / 7   18 / 21    11 / 25 
               χ
2 
(2) = 2.52       .12 
CY-BOCS, lifetime score           27.3 (6.7)           27.1 (6.2)   
    t(51) = 0.08    .94 
CY-BOCS, current score           22.4 (6.6)           14.2 (8.6)   
    t(51) = 3.21    .002                    
Age at onset of OCD symptoms (years)       7.0 (3.0)             8.9 (3.6)   
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Age at onset of MDD symptoms (years)    13.0 (1.9)                           13.6 (2.0) 
    t(51) = 0.92     .36 
Child Behavior Checklist 
  Obsessive-Compulsive Problems          6.9 (4.2)***†††  5.1 (3.4)***†††    3.0 (2.4)***      
0.9 (1.0)         F (3, 173) = 43.6   <.0001 
  Total score           50.1 (28.9)***    27.3 (18.5)***†    41.0 (27.8)***    
8.6 (9.3)        F (3, 173) = 41.7   <.0001    
 
 Internalizing score           21.4 (9.8)***        10.3 (7.8)***††† 17.1 (10.5)***   
3.2 (3.2)       F (3, 173) = 53.2   <.0001   
 
  Externalizing score           10.3 (9.0)***         5.1 (5.1)***          8.4 (9.4)***     
2.1 (3.4)        F (3, 173) = 14.7  <.0001   
 
  Affective Problems             8.6 (4.6)***    3.4 (3.1)***†††   7.8 (4.9)***     
0.6 (1.0)        F (3, 173) = 64.2  <.0001 
  Anxiety Problems             5.1 (3.5)***         3.4 (2.7)***         3.8 (2.9)***     
0.6 (1.0)       F (3, 173) = 36.3  <.0001 
  Somatic Problems             4.1 (3.4)***         1.2 (1.6)**†††      3.1 (2.9)***     
0.7 (1.4)       F (3, 173) = 20.6  <.0001         
  Attention Deficit/Hyperactivity Problems  3.7 (3.7)***         2.5 (2.8)***         2.9 (2.7)***     
0.9 (1.7)       F (3, 173) = 11.1  <.0001    
  Oppositional Defiant Problems            3.3 (2.3)***    2.0 (2.0)**           2.9 (2.5)***      
0.9 (1.4)       F (3, 173) = 14.4  <.0001    
  Conduct Problems              2.8 (3.9)*            0.8 (1.4)                2.4 (4.4)**       








Total number of trials            503.0 (52.3)        477.5 (53.9)        501.3 (34.0)      
490.6 (53.1)      F (3, 173) = 1.52      .21 Total number of error trials          46.7 
(36.8)         51.7 (24.5)**†     38.4 (16.9)      38.2 (19.7)      F (3, 173) = 3.64      .014     
Accuracy on all trials            0.90 (.07)          0.89 (.05)***†††   0.92 (.03)       
0.92 (.04)        F (3, 173) = 5.94      .0007    
Accuracy on congruent trials           0.98 (.03)          0.96 (.03)**†     0.98 (.02)          
0.98 (.02)        F (3, 173) = 2.65      .051   Accuracy on incongruent trials          0.83 (.12)          
0.81 (.08)***†††  0.86 (.06)       0.86 (.06)      F (3, 173) = 5.84      .0008 
Accuracy after correct trials           0.91 (.05)          0.88 (.05)***††    0.92 (.04)       
0.92 (.04)        F (3, 173) = 6.02     .0006 
Accuracy after incorrect trials          0.88 (.13)*††    0.90 (.04)*†††     0.96 (.01)       
0.93 (.06)        F (3, 173) = 6.12     .0006   Error reaction time (ms)                    432.7 (156.8)     
374.6 (70.7)   365.6 (34.6)      409.5 (147.8)    F (3, 173) = 2.26      .08 
Correct reaction time (ms)                    474.1 (116.0)     427.8 (59.2)   423.4 (35.1)     
447.7 (90.1)      F (3, 173) = 2.62      .052 
Reaction time on congruent trials (ms)     444.2 (69.8)       400.3 (53.5)   395.8 (32.0)     
418.6 (78.3)       F (3, 173) = 3.21      .02    
Reaction time on incongruent trials (ms)  512.2 (147.6)     460.9 (66.6)   455.2 (41.1)     
481.2 (105.1)     F (3, 173) = 2.13     .10 
Post-error slowing (ms)                      48.6 (34.8)         57.4 (32.6)           67.8 (40.7)        
41.1 (66.8)       F (3, 173) = 2.32     .08 
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Error-related negativity, FCz (µV)          -7.75 (8.26)*     -3.85 (4.94)         -5.14 (5.24)      -
4.18 (5.46)        F (3, 172) = 2.29     .08            
Correct response negativity, FCz (µV)         3.13 (5.05)        3.17 (4.95)          3.55 (5.08)       
3.24 (4.34)       F (3, 172) = 1.69     .14 
Error-related negativity, Cz (µV)          -4.97 (6.76)*     -1.96 (5.23)    -2.11 (5.14)      -
1.17 (5.93)       F (3, 172) = 2.98     .03         
Correct response negativity, Cz (µV)           3.47 (4.74)         4.43 (5.54)          4.97 (5.95)         
4.60 (4.86)       F (3, 172) = 0.50     .69 
Error-related negativity, CPz (µV)          -0.78 (4.70)**†  1.88 (4.60)*     2.07 (4.36)        
2.74 (5.28)       F (3, 172) = 3.51     .02            
Correct response negativity, CPz (µV)         4.21 (5.10)        6.00 (5.37)     6.18 (5.67)          
5.41 (4.73)      F (3, 172) = 0.81     .49 
∆ERN, FCz (µV)           -10.88 (9.63)      -7.02 (5.42)    -8.69 (6.53)       
-7.42 (6.52)      F (3, 172) = 1.21     .31 
∆ERN, Cz (µV)             -8.44 (8.08)      -6.40 (6.10)         -7.08 (7.76)       
-5.77 (6.65)      F (3, 172) = 0.96     .41 
∆ERN, CPz (µV)             -4.99 (7.58)      -4.12 (5.59)    -4.11 (6.50)       




OCD, obsessive-compulsive disorder;  
MDD, major depressive disorder; 
CY-BOCS, Children’s Yale-Brown Obsessive Compulsive Scale; 
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∆ERN, error-related negativity amplitude minus correct response negativity amplitude. 
*P < .05 compared to HC, **
 
P < .01 compared to HC, ***P < .001 compared to HC. 





TABLE 3. Correlation matrix for Child Behavior Checklist DSM-Oriented Scales, error-
related negativity (ERN), correct response negativity (CRN), and ERN minus CRN (ΔERN) 
at electrode Cz in 178 adolescent participants 
                                   Attention 
Deficit/       Oppositional  
                                                      Affective              Anxiety             Somatic       
Hyperactivity               Defiant        Conduct 
                                                       Problems            Problems            Problems             
Problems                Problems           Problems 
                         
__________________________________________________________________________________
_____             
Affective Problems                                  1                    0.72****            0.64****             
0.58****      0.68****        0.57****              
Anxiety Problems              0.72****              1                   0.43****             
0.48****      0.44****        0.36****           
Somatic Problems                 0.64****    0.43****               1                       
0.38****      0.48****           0.47****            
Attention Deficit/Hyperactivity            0.58****
  
   0.48****




       0.62****
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Problems                                         
Oppositional Defiant Problems            0.68****
 
          0.44****
 
      0.48****
  
          
0.62****
 
                  1                    0.69****
 
Conduct Problems                0.57****           0.36****           0.47****              
0.61****          0.69****           1             
ERN, Cz                             -0.15*                -0.27***      -0.15*           -0.06                      
-0.07        -0.08            
CRN, Cz                           -0.04                -0.003                -0.04                    -0.13                  -0.04        -0.06    
 
∆ERN, Cz                         -0.16*                -0.23**              -0.10                    -0.04                  -0.04                  -0.03             
 
∆ERN, error-related negativity amplitude minus correct response negativity amplitude. 
*
 
P < .05, **
 
P < .01, ***
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Figure 1. Grand averages of electroencephalogram (EEG) recordings in patients with 
obsessive-compulsive disorder (OCD), major depressive disorder (MDD), and healthy 
controls (HC). Note: The images depict response-locked grand average waveforms recorded 
at the central (Cz) electrode for correct and incorrect responses. Responses occurred at 0 ms. 
The mean amplitude of the error-related negativity (ERN) was computed in a window 0 to 80 
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Figure 2. Grand averages of electroencephalogram (EEG) recordings in patients with both 
obsessive-compulsive disorder (OCD) and major depressive disorder (MDD) (OCD+MDD), 
OCD without MDD (OCD-MDD), MDD, and healthy controls (HC). Note: The images 
depict response-locked grand average waveforms recorded at the central (Cz) electrode for 
correct and incorrect responses. Responses occurred at 0 ms. The mean amplitude of the 
error-related negativity (ERN) was computed in a window 0 to 80 ms after incorrect response 
trials.  
 
